Aspirin for the Prevention of Early and Severe Pre-Eclampsia Recurrence: A Real-World Population-Based Study.
Grégory LaillerClémence GraveAmélie GabetNolwenn RegnaultCatherine Deneux-TharauxSandrine KretzVassilis TsatsarisGeneviève Plu-BureauJacques BlacherValérie OliePublished in: Drugs (2023)
In women with a history of pre-eclampsia, aspirin initiation during a second pregnancy and adherence to the prescribed dosage were largely insufficient, especially for women experiencing social deprivation. Aspirin initiated before 16 WG at a dose ≥ 100 mg/day was associated with a lower risk of severe and early pre-eclampsia.
Keyphrases
- low dose
- cardiovascular events
- antiplatelet therapy
- early onset
- pregnancy outcomes
- healthcare
- mental health
- anti inflammatory drugs
- polycystic ovary syndrome
- preterm birth
- percutaneous coronary intervention
- acute coronary syndrome
- cardiovascular disease
- coronary artery disease
- metabolic syndrome
- type diabetes
- atrial fibrillation
- breast cancer risk